Filing metadata

Accession number
0001628280-21-012730
Form type
Form 4
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Jun 23, 2021
Reporting period
Jun 22, 2021
Description
Insider transaction

Explore SEC Filings Hub